| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 08/19/2003 | CA2100777C Pharmaceutical composition containing granisetron and dexamethasone |
| 08/14/2003 | WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 08/14/2003 | WO2003066824A2 Albumin-fused kunitz domain peptides |
| 08/14/2003 | WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency |
| 08/14/2003 | WO2003066085A1 Albumin-fused anti-angiogenesis peptides |
| 08/14/2003 | WO2003066078A1 Hiv inhibiting proteins |
| 08/14/2003 | WO2003066037A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
| 08/14/2003 | WO2003066034A2 Use of compounds and compositions derived form olives for protecting cells against dna damage |
| 08/14/2003 | WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser |
| 08/14/2003 | WO2003065871A2 Methods and compositions for treating hematological disorders |
| 08/14/2003 | WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/14/2003 | US20030153512 An etherification product of curcumin and saccharide glucose, use as antitumor agents treating cancer, antiinflammatory agents and viricides for treating a retrovirus infections |
| 08/14/2003 | US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures |
| 08/14/2003 | US20030153502 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor |
| 08/14/2003 | US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia |
| 08/14/2003 | US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 08/14/2003 | US20030152600 Novel compounds of the n-acylamino-amide-family, cpmpositions comprising same, and uses |
| 08/14/2003 | CA2485064A1 Albumin-fused kunitz domain peptides |
| 08/14/2003 | CA2475539A1 Hiv inhibiting proteins |
| 08/14/2003 | CA2475382A1 Albumin-fused anti-angiogenesis peptides |
| 08/14/2003 | CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 08/14/2003 | CA2473182A1 Compositions and methods for treatment of vitamin d deficiency |
| 08/13/2003 | EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/13/2003 | CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses |
| 08/13/2003 | CN1436180A Diamino phenothiazine derivs. and composition comprising same |
| 08/13/2003 | CN1436047A Compositions and methods for improving vascular health |
| 08/13/2003 | CN1435179A Biologic converted ginseng composition and preparing process thereof |
| 08/12/2003 | US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 08/12/2003 | US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid |
| 08/12/2003 | US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/12/2003 | US6605610 Aryl fused azapolycyclic compounds |
| 08/12/2003 | US6605270 Iron-binding polymers for oral administration |
| 08/07/2003 | WO2003064472A2 Treatment of ms with goat serum |
| 08/07/2003 | WO2002068476A3 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 08/07/2003 | US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 08/07/2003 | US20030149090 Topically delivering an effective dose of a reactvie oxygen metabolites (ROM) production and release inhibitory compound in carrier to a subject suffering from ROM-mediated oxidative damage |
| 08/07/2003 | US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis |
| 08/07/2003 | US20030149058 Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/07/2003 | US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 08/07/2003 | US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation |
| 08/06/2003 | EP1331946A2 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 08/06/2003 | EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 08/06/2003 | EP1331855A2 Aged companion pet diet |
| 08/06/2003 | EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 08/06/2003 | EP0824353A4 Methods to inhibit acute radiation-induced skin damage |
| 08/06/2003 | CN1116871C Pharmaceutical compositions and containing S-alkylisothiouronium derivatives |
| 08/06/2003 | CN1116870C Applicatino of preventing and treating peripheral neurophathy by administering selegiline |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 07/31/2003 | WO2003061757A1 Transdermal/transmucosal preparations for electroporation |
| 07/31/2003 | WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/31/2003 | WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 07/31/2003 | WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | WO2003061620A2 Peptide-carrying bodies for immune response |
| 07/31/2003 | WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | US20030144354 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents |
| 07/31/2003 | US20030144334 Cyclopentabenzofuran derivatives and their use |
| 07/31/2003 | US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144210 Treatment of neurologic and psychiatric disorders |
| 07/31/2003 | US20030143269 Tamper-resistant oral opioid agonist formulations |
| 07/31/2003 | DE20305898U1 Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473490A1 Peptide-carrying bodies for immune response |
| 07/31/2003 | CA2473395A1 Phospholipid bodies and use thereof in medical treatment |
| 07/31/2003 | CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/30/2003 | EP1330467A2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1075256B1 Arylhydrocarbon receptor ligand antagonists |
| 07/30/2003 | EP0966286B1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/30/2003 | CN1432357A Fever allaying prepn containing xylitol |
| 07/30/2003 | CN1116050C Medicine pill for dredging thje channel generating and nourishing the blood and removing toxic |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600021 Enzyme inhibitor for use in the preparation of dough and baked goods |
| 07/29/2003 | US6599537 Antiradical, cytophotoprotective, tyrosinase and melanogenesis inhibiting and antiprotease effects |
| 07/29/2003 | US6599498 Enhanced magnetic resonance imaging agent and a hematinic agent; carboxyalkylated reduced polysaccharides coated ultrasmall superparamagnetic iron oxides; carboxymethyl reduced dextran as a plasma extender |
| 07/29/2003 | CA2132982C Catalytic antibodies against cocaine and methods of using and producing same |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059368A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002049575A3 Method and composition for the treatment of diabetic neuropathy |
| 07/24/2003 | WO2002019982A3 Cosmetic composition and method for reducing or preventing wrinkling |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139323 Preradiation therapy; side effect reduction |
| 07/24/2003 | US20030138507 Plant extracts with anti-radical type action |
| 07/24/2003 | US20030138467 Methods for improving the aesthetic appearance of skin |
| 07/24/2003 | CA2474239A1 Substituted pyridazinones as inhibitors of p38 |
| 07/23/2003 | EP1329511A1 Polypeptide having phospholipase a2 actiivty |
| 07/23/2003 | EP1329222A1 Isoflavone compositions for use in medicine |
| 07/23/2003 | EP1328525A2 2,3,4,5-tetrahydro-1h-[1,4]diazepino[1,7-a]indole compounds |
| 07/23/2003 | EP1328282A1 Efficient method for producing compositions enriched in anthocyanins |
| 07/23/2003 | EP1328268A1 Combination of catechin and quercetin for pharmaceutical or dietary use |